TransCode Therapeutics, Inc. (RNAZ)
10.62
+1.99
(+23.06%)
USD |
NASDAQ |
Dec 11, 16:00
10.36
-0.26
(-2.45%)
After-Hours: 18:22
TransCode Therapeutics EPS Diluted (Quarterly): -5.825 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 1.947 |
| Eli Lilly & Co. | 6.211 |
| Aquestive Therapeutics, Inc. | -0.1397 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.856M |
| Total Expenses (Quarterly) | 4.856M |
| Enterprise Value | 4.358M |
| Earnings Yield | -2.28K% |
| Normalized Earnings Yield | -1754.24 |